Related Experiment Video

Updated: Apr 7, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.2K

Implications of Akt2/Twist crosstalk on breast cancer metastatic outcome

Lucília Pereira1, Sara Horta2, Rita Mateus2

  • 1Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.

Drug Discovery Today
|July 3, 2015
PubMed

Insights

Akt2 signaling is crucial for cancer growth and resistance to chemotherapy. Targeting Akt2 may offer new therapeutic strategies to improve cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Akt2 is a key regulator of cell growth, proliferation, and survival.
  • Aberrant Akt2 signaling contributes to tumor progression, metastasis, and chemoresistance.
  • Akt2 is involved in the Phosphat 3 kinase/Akt/Mammalian target of rapamycin (PI3K/mTOR) pathway, regulating metabolism.

Purpose of the Study:

  • To investigate the role of Akt2 in cancer, particularly in relation to stem cell-like properties.
  • To explore Akt2's involvement in invasiveness and chemoresistance, potentially mediated by Twist.
  • To propose therapeutic strategies targeting Akt2 for improved cancer therapy.

Main Methods:

  • Signaling pathway analysis
  • Cancer cell line studies
  • Molecular mechanism investigation

Main Results:

  • Akt2 deregulation is linked to tumor progression and chemoresistance.
  • Akt2 promotes stem cell-like properties, invasiveness, and chemoresistance, partly via Twist.
  • The PI3K/mTOR pathway is implicated in Akt2-driven processes.

Conclusions:

  • Akt2 plays a critical role in cancer development and treatment resistance.
  • Targeting Akt2, especially in conjunction with pathways like PI3K/mTOR and factors like Twist, presents a promising therapeutic avenue.
  • Further research into Akt2 inhibition could lead to overcoming current cancer therapy limitations.

More Related Videos

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

8.9K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.9K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K